Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Adverse events related to the eradication medication is one of the reason of lower eradication success in the H. pylori treatment. The aim of this study was to evaluate the additive effect of trimebutine for the development of adverse events related to the H. pylori eradication regimen.
Epistemonikos ID: 65aa47113ee0245422e30fb76a15b4abc24ad65f
First added on: May 07, 2024